ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT06904378 · RECRUITING
Trial details
- NCT number
- NCT06904378
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-25
- Primary completion
- 2028-09-30
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.